股票行情快报：稳健医疗（300888）2月5日主力资金净买入625.52万元

Group 1 - The core viewpoint of the news is that Steady Medical (300888) has shown significant growth in its financial performance, with a notable increase in revenue and net profit for the first three quarters of 2025 compared to the previous year [2] - As of February 5, 2026, Steady Medical's stock closed at 35.87 yuan, reflecting a 0.82% increase, with a trading volume of 41,100 hands and a total transaction amount of 148 million yuan [1] - The company reported a main business revenue of 7.32 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 30.1%, and a net profit attributable to shareholders of 732 million yuan, up 32.36% year-on-year [2] Group 2 - In the third quarter of 2025, the company achieved a single-quarter main business revenue of 2.6 billion yuan, which is a 27.71% increase year-on-year, and a net profit of 240 million yuan, reflecting a 42.11% year-on-year growth [2] - The company has a debt ratio of 33.87% and reported an investment income of 33.23 million yuan, with financial expenses of -2.036 million yuan and a gross profit margin of 48.32% [2] - Over the past 90 days, 11 institutions have rated the stock, with 9 buy ratings and 2 hold ratings, and the average target price set by institutions is 54.51 yuan [2]